China Biologic Products Holdings Inc (NASDAQ:CBPO)

100.99
Delayed Data
As of Jun 22
 -0.01 / -0.01%
Today’s Change
71.85
Today|||52-Week Range
113.88
+28.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.8B

Company Description

China Biologic Products Holdings, Inc. manufactures and distributes plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China.

Contact Information

China Biologic Products Holdings, Inc.
Jialong International Building
Beijing Beijing 100125
P:861065983111
Investor Relations:
861065983099

Employees

Shareholders

Mutual fund holders32.00%
Other institutional29.64%
Individual stakeholders--

Top Executives

Xiao Ying GaoChairman & Chief Executive Officer
Ming YangChief Financial & Accounting Officer